ProQR Therapeutics (PRQR) Change in Cash (2013 - 2026)

ProQR Therapeutics (PRQR) has reported Change in Cash for 14 consecutive years, with -$13.2 million the latest figure, recorded in Q1 2026.

• Quarterly Change in Cash rose 29.71% year-over-year to -$13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$57.7 million (down 208.95% YoY) and the FY2025 annual result came in at -$63.3 million, down 286.67% from the prior year.
• Change in Cash advanced to -$13.2 million in Q1 2026 per PRQR's latest filing, from -$16.5 million in the prior quarter.
• Over the last five years, Change in Cash for PRQR reached as high as $67.5 million in Q4 2024 and fell as low as -$67.6 million in Q3 2022.
• A 5-year average of -$7.6 million and a median of -$13.2 million in 2026 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash tumbled 487.24% — and 2024, when it soared 4293.35%.
• Year by year, Change in Cash stood at -$4.6 million in 2022, then surged by 65.09% to -$1.6 million in 2023, then surged by 4293.35% to $67.5 million in 2024, then sank by 124.42% to -$16.5 million in 2025, then advanced by 19.81% to -$13.2 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$13.2 million, -$16.5 million, and -$14.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.